AKT1 and meningioma: More recent work from our lab has added another layer to the molecular landscape by describing a hormonally controlled PI3KCA–PI3K–AKT pathway in a subgroup of meningiomas, involving endocrine signaling in tumorigenesis through isoform-specific PI3KCA mutations [67].